Related Experiment Videos
[Primary mediastinal non-seminomatous germ-cell tumors: from clinics to biology]
1Département de médecine oncologique, Institut Gustave-Roussy, Villejuif, France.
Abstract:
Primary mediastinal non-seminomatous germ-cell tumors (PMNSGCTs) are rare neoplasms that occur in young male adults. Incidence is evaluated about half that of extra-gonadal GCT. Their treatment is generally based on protocols used for testicular cancer, but with poorer results. Based on our experience of 40 patients with PMNSGCTs and data from the literature, we review here the clinical and biological data of these neoplasms. PMNSGCTs seem to constitute a specific entity, distinct from other GCT by the following criteria: true extra-gonadal origin, high incidence in patients with the Klinefelter's syndrome, over-representation of the yolk-sac component, poorer chemosensitivity and survival compared to other GCT, frequent occurrence of non-treatment related hematological neoplasia. The finding of an isochromosome of the short arm of the chromosome 12 in the leukemic karyotype is one of the strongest argument for a common origin in the yolk-sac component of the PMNSGCTs and their associated leukemia. Treatment of PMNSGCTs is still a challenge and should be conducted by a well-trained medical team.
Insights
Primary mediastinal non-seminomatous germ-cell tumors (PMNSGCTs) are rare in young men. These tumors, distinct from other germ-cell tumors, present unique challenges in treatment and survival.
Area of Science:
- Oncology
- Genetics
- Pathology
Context:
- Primary mediastinal non-seminomatous germ-cell tumors (PMNSGCTs) are rare neoplasms.
- Incidence is approximately half that of extra-gonadal germ-cell tumors (GCT).
- Treatment protocols, adapted from testicular cancer, yield poorer outcomes.
Purpose:
- To review clinical and biological data of PMNSGCTs.
- To highlight distinct characteristics of PMNSGCTs compared to other GCTs.
- To discuss challenges in PMNSGCT treatment.
Summary:
- PMNSGCTs exhibit a true extra-gonadal origin.
- Associated with Klinefelter's syndrome and over-representation of the yolk-sac component.
- Demonstrate poorer chemosensitivity, survival, and frequent hematological neoplasia.
- Isochromosome 12p in leukemic karyotype suggests a common origin with yolk-sac component.
Impact:
- PMNSGCTs represent a distinct clinicopathological entity.
- Effective treatment strategies for PMNSGCTs remain a significant challenge.
- Requires management by specialized medical teams for optimal patient care.